[DISCLOSURE]
Green Cross Medical Science (142280) announced on Nov. 26 that it has received a 30.27 billion won (US$26.78 million) order from Korean Red Cross to supply nucleic acid amplification testers.
This amounts to 30.77 percent of its 2017 revenue and the contract is valid from Dec. 15, 2018 to Dec. 14, 2020.
By Hwang You-mee (
glamazon@heraldcorp.com)